Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
JHEP Rep15 Mar 2025

Discovery of key players in lymph node metastasis of ICCA

Single-cell analyses reveal significant insights into lymph node metastasis in intrahepatic cholangiocarcinoma (ICCA). A complex heterogeneity was identified within the lymph node microenvironment, with an increase in stromal and mature immune cells, particularly diverse T cell subtypes. Notably, CD36+ macrophages and SAA1+ tumor cells were…

Surg Endosc14 Mar 2025

Improved prediction model for 5-year postoperative HCC recurrence

A new predictive model significantly enhances the accuracy of forecasting 5-year recurrence rates in hepatocellular carcinoma (HCC) patients post-surgery. Integrating LASSO regression and random forest techniques, the model identified six key factors, achieving an area under the curve (AUC) of 0.733, compared to the initial…

Clin J Gastroenterol14 Mar 2025

Pembrolizumab shows promise for rare microsatellite-high intrahepatic cholangiocarcinoma

A 65-year-old man with unresectable, microsatellite-high intrahepatic cholangiocarcinoma experienced significant tumor shrinkage after receiving pembrolizumab, following a failed combination therapy. The comprehensive cancer genomic profiling identified an mlh1 pathogenic mutation, suggesting the microsatellite instability was somatic rather than inherited. Remarkably, the response was maintained for…

Int J Surg13 Mar 2025

Radiation-emitting metallic stents improve survival in cholangiocarcinoma

A multicenter trial demonstrated that radiation-emitting metallic stents (REMS) combined with hepatic arterial infusion chemotherapy (HAIC) significantly outperformed self-expandable metallic stents (SEMS) in patients with unresectable Bismuth type III or IV perihilar cholangiocarcinoma. The median overall survival was 10.2 months for REMS compared to 6.7…

Int J Surg13 Mar 2025

Triple therapy enhances survival in advanced hepatocellular carcinoma.

In high-risk advanced hepatocellular carcinoma patients, triple therapy involving FOLFOX-based hepatic arterial infusion, tyrosine kinase inhibitors, and PD-1 inhibitors significantly improved median overall survival to 24.6 months compared to 11.9 months with dual therapy (HR=0.43, p

Int J Surg13 Mar 2025

New model predicts postpancreatectomy hemorrhage risk accurately

A novel predictive model using lasso-logistic regression has been developed to assess the risk of postpancreatectomy hemorrhage. Analyzing data from over 9,600 patients, the model identifies nine independent risk factors, including preoperative BMI and ASA scores. Its predictive accuracy reached an area under the ROC…

Eur J Surg Oncol12 Mar 2025

Standardized training for colorectal liver metastases established

A new structured guide addressing colorectal liver metastases (CRLM) fills a vital gap in surgical oncology education. By updating the European Society of Surgical Oncology's curriculum, it provides essential information on epidemiology, staging, and treatment strategies. Researchers conducted a thorough literature review, focusing on recent…

Eur J Surg Oncol12 Mar 2025

New tool enhances risk prediction for liver surgery complications

A dynamic tool utilizing albumin-bilirubin (ALBI) scores and fibrosis-4 (FIB-4) index trends improves risk stratification for patients undergoing hepatocellular carcinoma resection. K-means clustering revealed three patient groups with varying complication risks. Those in the lowest ALBI cluster had a 76% reduced odds of severe complications…

HPB (Oxford)12 Mar 2025

Acute pancreatitis incidence and mortality remain significant in England

An analysis of 260,009 acute pancreatitis patients in England from 2013 to 2023 reveals an incidence rate rising by 2.6% annually, with 456 cases per million. In-hospital mortality stands at 4.5%, while the 10-year survival rate reaches 63.9%. Factors influencing better long-term outcomes include biliary…

Gastrointest Endosc11 Mar 2025

EUS-FNB significantly enhances diagnosis of autoimmune pancreatitis

A prospective multicenter study evaluated the effectiveness of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) in diagnosing autoimmune pancreatitis (AIP) using the International Consensus Diagnostic Criteria (ICDC). Results showed that EUS-FNB improved diagnostic levels in 92.3% of suspected AIP patients, with a diagnostic accuracy of 94.2%. The…